NERI, BRUNO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.532
EU - Europa 6.257
AS - Asia 3.616
SA - Sud America 447
AF - Africa 100
OC - Oceania 98
Continente sconosciuto - Info sul continente non disponibili 70
Totale 20.120
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.379
RU - Federazione Russa 2.212
IT - Italia 1.212
SG - Singapore 1.059
CN - Cina 790
HK - Hong Kong 593
IE - Irlanda 472
UA - Ucraina 446
VN - Vietnam 443
PL - Polonia 425
SE - Svezia 414
DE - Germania 375
BR - Brasile 352
KR - Corea 295
FI - Finlandia 203
FR - Francia 196
GB - Regno Unito 141
IN - India 126
CA - Canada 99
AU - Australia 96
CH - Svizzera 79
JO - Giordania 62
TR - Turchia 36
BD - Bangladesh 35
JP - Giappone 31
ID - Indonesia 29
AR - Argentina 28
EC - Ecuador 24
NL - Olanda 24
IQ - Iraq 23
SC - Seychelles 23
CI - Costa d'Avorio 18
MX - Messico 17
NG - Nigeria 17
ES - Italia 15
BE - Belgio 12
PH - Filippine 12
PK - Pakistan 12
VE - Venezuela 12
CR - Costa Rica 11
PY - Paraguay 10
AE - Emirati Arabi Uniti 9
AZ - Azerbaigian 9
CO - Colombia 9
MA - Marocco 9
ZA - Sudafrica 9
TN - Tunisia 7
UZ - Uzbekistan 7
OM - Oman 6
SA - Arabia Saudita 6
CZ - Repubblica Ceca 5
JM - Giamaica 5
KE - Kenya 5
KG - Kirghizistan 5
LT - Lituania 5
EG - Egitto 4
GT - Guatemala 4
HN - Honduras 4
IR - Iran 4
KZ - Kazakistan 4
PE - Perù 4
TH - Thailandia 4
TW - Taiwan 4
CL - Cile 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
AL - Albania 2
AO - Angola 2
AT - Austria 2
BG - Bulgaria 2
BO - Bolivia 2
CD - Congo 2
DK - Danimarca 2
MY - Malesia 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PA - Panama 2
PR - Porto Rico 2
PT - Portogallo 2
RO - Romania 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
BZ - Belize 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
KH - Cambogia 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
Totale 20.046
Salva come PNG Salva come JPEG
Città #
Santa Clara 2.486
Ashburn 740
Jacksonville 687
Singapore 676
Chandler 586
Dublin 471
Hong Kong 469
San Jose 427
Warsaw 420
Fairfield 408
Milan 294
Seoul 292
Cambridge 193
Beijing 186
Wilmington 183
Woodbridge 179
Council Bluffs 170
Buffalo 169
Seattle 163
Boardman 152
Houston 151
Los Angeles 147
Princeton 139
Ho Chi Minh City 135
Lauterbourg 122
Hefei 112
Boston 111
Hanoi 103
Rome 102
The Dalles 102
Ann Arbor 98
Mumbai 95
Melbourne 94
Munich 94
New York 78
Bern 77
Medford 66
Florence 62
Shanghai 57
Columbus 48
Moscow 48
Phoenix 48
Altamura 45
Lawrence 44
Paris 41
Helsinki 39
Naples 39
Kent 35
Dallas 34
Turku 34
San Diego 32
Figino 31
Tokyo 30
Toronto 29
Turin 28
São Paulo 27
Auburn Hills 26
Norwalk 24
Orem 24
Palermo 24
Verona 24
Frankfurt Am Main 22
Frankfurt am Main 22
Haiphong 22
Izmir 22
Hillsboro 20
Montreal 19
Abidjan 18
Chicago 18
Da Nang 18
Andover 17
Brooklyn 17
Jakarta 17
Yubileyny 17
San Francisco 16
Abuja 15
Bologna 15
Portsmouth 15
Bari 14
Denver 13
London 13
Rio de Janeiro 12
San José 11
Venice 11
Brasília 10
Brussels 10
Clifton 10
Genoa 10
Guayaquil 10
Manchester 10
Poplar 10
Shenzhen 10
Stockholm 10
Baghdad 9
Belo Horizonte 9
Biên Hòa 9
Brescia 9
Dearborn 9
Guangzhou 9
Quito 9
Totale 12.587
Salva come PNG Salva come JPEG
Nome #
GEMCITABINE PLUS IRINOTECAN AS FIRST-LINE WEEKLY THERAPY IN LOCALLY ADVANCED AND/OR METASTATIC PANCREATIC CANCER 359
Oxaliplatin, 5-fluorouracil/leucovorin and epirubicin as first-line treatment in advanced gastric carcinoma: A phase II study 349
Biweekly sunitinib regimen reduces toxicity and retains efficacy in metastatic renal cell carcinoma: A single-center experience with 31 patiens 230
SURVIVAL AND PROGNOSTIC FACTORS IN PATIENTS WITH HEPATOCELLULAR CARCINOMA TREATED BY PERCUTANEOUS ETHANOL INJECTION: A 10-YEAR EXPERIENCE. 228
ROLE OF CONVENTIONAL TREATMENTS ON CIRCULATING AND MONOCYTE-DERIVED DENDRITIC CELLS IN COLORECTAL CANCER 218
Treatment of locally advanced hepatocellular carcinoma by hepatic intra-artery chemotherapy: a pilot study. 217
Long-term survival in metastatic melanoma patients treated with sequential biochemotherapy: report of a Phase II study. 215
Variazioni circadiane della capacità totale di ferro fissazione di un gruppo di soggetti sani 199
Weekly gemcitabine plus Epirubicin as effective chemotherapy for advanced pancreatic cancer: a multicenter phase II study 199
Studio prospettico sul carcinoma del colon e angiogenesi: risultati preliminari 198
Asymptomatic synchronous brain metastasis of low rectal cancer; cancer report and review 196
P53 and DPC4 alterations in the bile of patients with pancreatic carcinoma 188
Effects of Melatonin administration on cytochine production in patients with advanced solid tumors 185
Antiproliferative activity of melatonin by transcriptional inhibition of cyclin D1 expression: a molecular basis for melatonin-induced oncostatic effects. 185
Variazioni circadiane delle proteine sieriche in soggetti apparentemente sani 183
Phase II trial of weekly intravenous gemcitabine administration with interferon and interleukin-2 immunotherapy for metastatic renal cell cancer. 181
An uncommon clinical presentation of retroperitoneal non-Hodgkin lymphoma successfully treated with chemotherapy: a case report 180
Raltitrexed plus oxaliplatin as first-line chemotherapy in metastatic colorectal carcinoma: a multicentric phase II trial. 179
Weekly administration of docetaxel and epirubicin as first-line treatment for hormone refractory prostate cancer 179
"ADJUVANT CHEMOTHERAPY AFTER GASTRIC RESECTION IN NODE POSITIVE CANCER PATIENS: A MULTICENTRIC RANDOMIZED STUDY" 179
Beta2-microglobulina, marker tumorale nel mieloma multiplo 178
"DIFFERENCES BETWEEN CARNITINE DERIVATIVES AND COENZYME Q10 IN PREVENTING IN VITRO, DOXORUBICIN RELATED CARDIAC DAMAGES" 177
"ANTHRACYCLINE CARDIOTOXICITY: IN VIVO AND ON VITRO EFFECTS" 175
An uncommon clinical onset of colonic cancer: peripheral paraneoplastic neuropathy 172
D2 resection for gastric cancer in aged patient 172
Melatonin's growth-inhibitory effect on hepatoma AH 130 in the rat. 172
Aspetti circadiani del metabolismo del ferro 171
Gemcitabine plus docetaxel as first-line biweekly therapy in locally advanced and/or metastatic urothelial carcinoma: a phase II study 171
Creatine Kinase isoenzyme BB : a lung cancer associated marker 170
Gemcitabine plus irinotecan as first line weekly therapy in locally advanced and/or metastatic pancreatic cancer 170
Melatonin as Biological Response Modifier in Cancer Patients 168
Behaviour of atrial natriuretic factor in anthracycline-related cardiac toxicity 168
"CONVENTIONAL VS HIGH DOSE EPIDOXORUBICIN AS SINGLE AGENT IN ADVANCED BREAST CANCER" 168
Modulation by Lonidamine of the antiproliferative activity of Adriamycin on Yoshida hepatoma of the rat 167
CHRONOBIOLOGICAL ASPECTS OF PHOSPHOHEXOSE-ISOMERASE IN MONITORING MULTIPLE MYELOMA 167
Cyclophosphamide, epirubicin and carboplatin as treatment for advanced carcinoma of the bladder: a phase II study 166
Circadian rhythm in several components of the complement cascade in healthy women 166
"OSTEOCALCIN AS A BIOLOGICAL MARKER IN THE MANAGEMENT OF BREAST CANCER BONE METASTASES" 165
Assessment of Phosphohexose-isomerase, Beta2-microgubulin and Ferritin in lung cancer 165
Adjuvant chemotherapy after gastric resection in node positive cancer patients: a multicentric randomized study 165
THE MULTIPLE DRUG RESISTANCE PHENOTYPE AND ITS CONSEQUENCES FOE CELL BIOLOGY OF CANCER CELLS 164
VENTRICULAR LATE POTENZIALS IN THE ASSESSMENT OF MITOXANTRONE CARDIOTOXICITY 162
Intra-arterial chemotherapy with 5-fluorouracil and 5-methyltetrahydrofolate in the treatment of unresectable liver metastases from colorectal cancer 162
Echocardiographic assessment of anthracycline cardiotoxicity during different therapeutic regimens 161
FERRITIN AS CHRONOBIOLOGICAL MARKER IN IMMUNOPROLIFERATIVE DISEASE 160
Postoperative chemotherapy in resected gastric cancer: results of a single center experience. 158
Weekly paclitaxel and epirubicin in the treatment of symptomatic hormone-refractory advanced prostate carcinoma:a phase II trial 157
Effetto cronofarmacologico della calcitonina porcina nella malattia ossea di Paget 155
Tyrosinase mRNA levels in the blood ofuveal melanoma patients: correlation with the number of circulating tumor cells and tumor progression. 154
Complete androgen blockade as treatment for advanted prostate cancer: clinical response and side-effects 154
"Circadian study of immunoreactive prolactin in patiens with cirrhosis of the liver" 153
Bioperiodicità dell'escrezione urinaria di catene leggere nel mieloma : un potenziale marker ritmico 153
"CIRCADIAN VARIATIONS OF PHOSPHOHEXOSE-ISOMERASE IN MULTIPLE MYELOMA" 153
Dose-finding study of gemcitabine and epirubicin in patients with advanced pancreatic cancer. 152
Aspetti cronobiologici del metabolismo proteico nella cirrosi epatica 152
Randomized trial of adjuvant chemotherapy versus control after curative resection for gastric cancer: 5-year follow-up. 152
Tecnica di laboratorio e bioritmi : studio circadiano di alcuni parametri emocitometrici 151
MICROARRAYS-BASED STUDY IN PANCREATIC CARCINOMA 151
The role of a new monoclonal antibody assay in the detection of recurrent breast cancer 151
Oncologia Clinica 150
Adriamycin and 4-Epi-Doxorubicin : Effects on endogenous respiration in rat heart slices 149
The role of CA 15-3 and MCA Monoclonal Antibody Assay in the detection of Primary and Recurrent Breast cancer 145
Variazioni circadiane della prolattina sierica in un gruppo di soggetti apparentemente sani 145
Hemopsy reveals circadian mesor decrease, amplitude increase and acrophase advance for the third component of complement in fibrocystic mastophaty 145
CLINICAL UTILITY OF COMBINED USE OF PLURIME TUMOR MARKERS IN HUMAN BREAST CANCER 145
Esiste un cronorischio nell'artero-sclerosi? 144
Results of leucovorin and doxifluridine oral regimen in the treatment of metastatic colorectal cancer 144
Preliminary study on behaviour of atrial natriuretic factor in anthracycline-related cardiac toxicity 142
Phosphohexose-isomerase as tumor marker in hepatoma bearing rats 142
Weekly epidoxorubicin therapy in hormone-refractory metastatic prostate cancer. 142
Circadian variation of serum prolactin and THS in women with health or with mammary carcinoma, fibroadenoma or fibrocystic mastopathy 142
Effects of melatonin administration in patients with advanced solid tumors 141
INHIBITION OF ENDOGENOUS RESPIRATION AS A MEASURE OF MITOXANTRONE CARDIAC TOXICITY 140
Effect of antracyclines and mitoxantrone on oxygen uptake and ATP intracellular concentration in rat heart slices 139
FEC VERSUS EM WITH OR WITHOUT LONIDAMINE AS FIRST-LINE TREATMENT FOR ADVANCED BREAST CANCER: A MULTICENTRIC RANDOMIZED STUDY. FINAL RESULTS 139
Clinical aspects of doxorubicin and epirubicin cardiotoxicity in cancerous patiens 137
Epirubicin high dose in advanced breast cancer: preliminary clinical data 136
Control of nephrotoxicity by hydration-diuresis, and of emesis by alizapride in patiens with bladder cancer 134
Biweekly sunitinib regimen reduces toxicity and retains efficacy in metastatic renal cell carcinoma: a single-center experience with 31 patients 133
STUDIO CON AUTOFLUORESCANZA SU LINFONODI METASTATICI NEI TUMORI DEL TRATTO GASTROENTERICO 131
Adjuvant chemotherapy after surgery for gastric cancer 131
Studio prospettico sul carcinoma del colon e angiogenesi: risultati preliminari 130
RECOMBINANT HUMAN ERYTHROPOIETIN IN THE TREATMENT OF CHEMOTHERAPY-INDUCED ANEMIA AND PREVENTION OF TRANSFUSION REQUIREMENT ASSOCIATED WITH SOLID TUMORS: A RANDOMIZED, CONTROLLED STUDY. 128
Reduction of cardiac toxicity of anthhracyclines by L-Carnitine: preliminary overview of clinical data 128
The efficacy and tolerability of a sunitinib 3-week administration schedule in metastatic renal cell carcinoma patients: report of three Cases 128
Doxorubicin and epirubicin cardiotoxicity: experimental and clinical aspects 128
Studio Chronobiologico della bilirubinemia in pazienti con cirrosi epatica 127
Long-term biochemotherapy with cytokines and gencitabine in metastatic renal cell cancer: a phase II study 127
Detection of circulating Immune Complex in Gynecological Malignancies 127
Clinical utility of the combined use of plurime tumor markers in human breast cancer 127
"COMBINATION CHEMOTHERAPY WITH EPIRUBICIN AND MYTOMICIN C AS FIRST-LINE TREATMENT IN ADVANCED BREAST CANCER" 126
CIRCULATING IMMUNE COMPLEXES AS TUMOR MARKERS IN THE FOLLOW UP BREAST CANCER 125
Doxorubicin plus Lonidamine: in vivo metabolic effects on the rat hearth 125
Free-radical production and nucleotide loss in anthracycline-induced cardiac damage 125
Cyclophosphamide, epidoxorubicin and Carboplatin as treatment for advanced-carcinoma of the bladder - a phase-ii study. 125
OBI/EPO-ITA-01/Italian study group.Correlation between variation in quality of life and change in hemoglobin level after treatment with epoietin alfa 40,000 IU administered once-weekly. 124
Controlli di qualità di metodiche radioimmunologiche : implicazioni cronobiologiche 124
Bio-markers in the detection of myeloproliferactive diseases : a combined study on Phosphohexose isomerase Beta2-microglobulin ad Ferritin 124
In vitro evaluation of organ metabolic toxicity of a new synthetic tripeptide versus L-phenylalanine-mustard 123
La prevalenza dell'anemia nei pazienti oncologici sottoposti a chemioterapia: Indagine Italiana a livello nazionale 123
Totale 16.085
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.533
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.533
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022667 0 0 13 70 22 18 18 44 26 13 225 218
2022/20232.149 219 224 111 150 230 409 272 137 240 11 51 95
2023/2024821 43 95 150 48 35 77 35 214 9 15 44 56
2024/20256.263 182 647 401 955 2.057 968 61 204 309 125 208 146
2025/20265.451 705 818 336 284 670 135 726 234 304 305 122 812
2026/2027939 175 251 513 0 0 0 0 0 0 0 0 0
Totale 20.120